FAKTOR-OPTIONSSCHEIN - RESMED | Market Closed - Bid/Ask 07:04:52 11/06/2024 BST | Pre-market 07:16:49 | |||
| 6.49 EUR | -1.37% |
|
6.565 | +1.16% |
| Current month | -3.94% | ||
| 1 month | +2.65% |
Comparison chart between the derivative product and it's underlying value
End-of-day quotes
Chart
RESMED, INC.
Latest news about RESMED, INC.
More news
| Date | Price | Change |
|---|---|---|
| 11/06/24 | 6.49 | -1.37% |
| 10/06/24 | 6.58 | +0.61% |
| 07/06/24 | 6.54 | +0.93% |
| 06/06/24 | 6.48 | +1.57% |
| 05/06/24 | 6.38 | -1.69% |
Delayed Quote Börse Stuttgart
Last update June 11, 2024 at 07:04 am
More quotesStatic data
| Product type | Exotic Products |
|---|---|
| Buy / Sell | CALL |
| Underlying | RESMED, INC. |
| Issuer | Morgan Stanley |
| WKN | MG2D1M |
| ISIN | DE000MG2D1M4 |
| Date issued | 16/04/2024 |
| Strike | 317.5 $ |
| Maturity | Unlimited |
| Parity | 15.08 : 1 |
| Emission price | 10 € |
| Emission volume | N/A |
| Settlement | cash |
| Currency | EUR |
Technical Indicators
| Highest since issue | 11.41 € |
|---|---|
| Lowest since issue | 5.95 € |
| Spread | 0.13 € |
| Spread % | 1.96% |
Company Profile
ResMed, Inc. specializes in designing, manufacturing and marketing respiratory disorders diagnosis, treatments and management (primarily sleep respiratory disorders). Net sales break down by family of products as follows:
- medical devices (50.4%);
- masks (37.9%);
- software as a service (11.7%).
At the end of June 2021, the group had 6 production sites located in the United States (2), Australia, China, Singapore and Malaysia.
The United States accounts for 61.4% of net sales.
Sector
-
Consensus: ResMed, Inc.
Sell
Buy
Mean consensus
OUTPERFORM
Number of Analysts
15
Last Close Price
211.7
USD
Average target price
218.7
USD
Spread / Average Target
+3.34%
- Stock Market
- Certificates
- Certificat
